A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EC / experimental allergic conjunctivitis

[Related PubMed/MEDLINE]
Total Number of Papers: 20
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EC  (>> Co-occurring Abbreviation)
Long Form:   experimental allergic conjunctivitis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2009 Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis. RW, TRAIL
2009 Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis. RW
2009 Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice. RW
2008 CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice. RW
2008 Depletion of thymus-derived CD4+CD25+ T cells abrogates the suppressive effects of alpha-galactosylceramide treatment on experimental allergic conjunctivitis. alpha-GalCer, RW
2008 Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis. RW, WT
2008 Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis. Dll, nhIgG, RW, WT
2008 Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice. Abs, nrIgG, RW
2007 Antibodies to T-cell Ig and mucin domain-containing proteins (Tim)-1 and -3 suppress the induction and progression of murine allergic conjunctivitis. Tim
10  2007 B7-H3 regulates the development of experimental allergic conjunctivitis in mice. ---
11  2007 Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis. CTLA-4, RW
12  2007 Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis. IL, IL-10KO, RW, Th1, WT
13  2007 T-cell Ig and mucin domain-containing protein (Tim)-2 regulates murine allergic conjunctivitis during the effector phase. RW, Tim
14  2007 Thymus-derived CD4+ CD25+ T cells suppress the development of murine allergic conjunctivitis. nrIgG, RW
15  2006 Analysis of the interaction between IFN-gamma and IFN-gammaR in the effector phase of experimental murine allergic conjunctivitis. ---
16  2006 CD8+ T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis. RW, WT
17  2006 Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice. Abs, nrIgG, PD-1, PD-L2, RW
18  2006 Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide. alpha-GalCer, RW
19  2006 Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40. nr, OX40L, RW
20  2005 The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis. Ab, B7RP, ICOS, IgG, RW